Bafna Pharma.

{
  "main_header": {
    "sid": 852453,
    "name": "Bafna Pharma.",
    "stock_name": "Bafna Pharma.",
    "full_name": "Bafna Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/bafna-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "308.70",
    "chg": -6.3,
    "chgp": "-2.0%",
    "dir": -1,
    "prev_price": "315.00",
    "mcapval": "745.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532989,
    "symbol": "BAFNAPH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE878I01022",
    "curr_date": "Sep 02, 10:30 AM",
    "curr_time": "10:32 AM",
    "last_traded_at": "Sep 02, 10:30 AM IST",
    "bse_nse_vol": "28.43 k",
    "exc_status": "Active",
    "traded_date": "Sep 02, 2026",
    "traded_date_str": "2026 09 02",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 318",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-of-rs318-4177406",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_priceRelatedfactors_4177406.png",
        "date": "2026-09-01 09:45:39",
        "description": "From a 52-week low of Rs 95 to a fresh peak of Rs 318, Bafna Pharmaceuticals Ltd has surged over 200% in the past year, defying the broader market’s subdued performance. This remarkable rally culminated in the stock hitting a new 52-week high on 1 Sep 2026, fuelled by a confluence of strong technical signals and sustained price momentum."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 4.6% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4176184",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_stocks_hitting_upper_circuit_4176184.png",
        "date": "2026-08-31 11:00:08",
        "description": "At Rs 304.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.6% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 303.85 on Back of Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs30385-4175657",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4175657.png",
        "date": "2026-08-31 09:49:50",
        "description": "From a 52-week low of Rs 95 to a fresh peak of Rs 303.85 on 31 Aug 2026, Bafna Pharmaceuticals Ltd has delivered an extraordinary 198.04% return over the past year, significantly outpacing the Sensex’s decline of 3.63%. This remarkable rally is underpinned by a broad alignment of technical indicators signalling sustained momentum."
      },
      {
        "title": "Bafna Pharmaceuticals Gains 17.57%: 6 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-1757-6-key-factors-driving-the-weeks-rally-4174443",
        "imagepath": "",
        "date": "2026-08-29 15:02:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>24 Aug:</strong> New 52-week high (Rs.254.55) and upper circuit hit</p>\n                    <p><strong>25 Aug:</strong> Upper circuit hit again amid strong buying momentum (Rs.267.25)</p>\n                    <p><strong>26 Aug:</strong> Third consecutive upper circuit hit (Rs.280.60)</p>\n                    <p><strong>27 Aug:</strong> Lower circuit hit amid heavy selling pressure (Rs.271.50)</p>\n                    <p><strong>28 Aug:</strong> New 52-week high and upper circuit hit (Rs.291.35)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.247.00</div></d..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 290.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-marking-significant-rally-4173699",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4173699.png",
        "date": "2026-08-28 14:15:19",
        "description": "Surging nearly 193% over the past year, Bafna Pharmaceuticals Ltd has now touched an intraday high of Rs 290.4, closing just 1.93% shy of its 52-week peak. This remarkable price momentum unfolds amid a backdrop of strong technical signals and a market environment where the broader Sensex trades cautiously below key moving averages."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 4.99% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4173197",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_stocks_hitting_upper_circuit_4173197.png",
        "date": "2026-08-28 10:00:21",
        "description": "At Rs 291.35, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.99% on 28 Aug 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 3.24% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4171348",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_stocks_hitting_lower_circuit_4171348.png",
        "date": "2026-08-27 10:00:22",
        "description": "At Rs 271.5, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 3.24% on 27 Aug 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4170004",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_mojoScore_4170004.png",
        "date": "2026-08-26 10:11:12",
        "description": "Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-momentum-4169863",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_stocks_hitting_upper_circuit_4169863.png",
        "date": "2026-08-26 10:00:32",
        "description": "At Rs 280.6, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 26 Aug 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 382,
    "sid": "852453",
    "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "21-Aug-2026",
      "details": "We herewith enclose the Newspaper Publication for the 31st Annual General Meeting of the Company published in Business Standard and Makkal Kural on August 20 2026.",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 31St Annual General Meeting Of The Company For The F.Y 2025-2026",
      "datetime": "19-Aug-2026",
      "details": "We herewith enclose the Notice of 31st Annual General Meeting of the Company scheduled to be held on Friday September 11 2026 at 10.00 A.M along with the Annual Report of the Company for the FY 2025-2026.",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "19-Aug-2026",
      "details": "We herewith enclose the Annual Report of the Company for the F.Y 2025-2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13",
          "dt": "2013-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 318

2026-09-01 09:45:39

From a 52-week low of Rs 95 to a fresh peak of Rs 318, Bafna Pharmaceuticals Ltd has surged over 200% in the past year, defying the broader market’s subdued performance. This remarkable rally culminated in the stock hitting a new 52-week high on 1 Sep 2026, fuelled by a confluence of strong technical signals and sustained price momentum.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 4.6% Gain — Buyers Queue, Sellers Absent

2026-08-31 11:00:08

At Rs 304.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.6% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 303.85 on Back of Strong Technical Signals

2026-08-31 09:49:50

From a 52-week low of Rs 95 to a fresh peak of Rs 303.85 on 31 Aug 2026, Bafna Pharmaceuticals Ltd has delivered an extraordinary 198.04% return over the past year, significantly outpacing the Sensex’s decline of 3.63%. This remarkable rally is underpinned by a broad alignment of technical indicators signalling sustained momentum.

Read full news article

Bafna Pharmaceuticals Gains 17.57%: 6 Key Factors Driving the Week’s Rally

2026-08-29 15:02:58

Key Events This Week

24 Aug: New 52-week high (Rs.254.55) and upper circuit hit

25 Aug: Upper circuit hit again amid strong buying momentum (Rs.267.25)

26 Aug: Third consecutive upper circuit hit (Rs.280.60)

27 Aug: Lower circuit hit amid heavy selling pressure (Rs.271.50)

28 Aug: New 52-week high and upper circuit hit (Rs.291.35)

Week Open

Rs.247.00

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 290.4

2026-08-28 14:15:19

Surging nearly 193% over the past year, Bafna Pharmaceuticals Ltd has now touched an intraday high of Rs 290.4, closing just 1.93% shy of its 52-week peak. This remarkable price momentum unfolds amid a backdrop of strong technical signals and a market environment where the broader Sensex trades cautiously below key moving averages.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 4.99% Gain — Buyers Queue, Sellers Absent

2026-08-28 10:00:21

At Rs 291.35, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.99% on 28 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 3.24% Loss — Sellers Queue, No Buyers in Sight

2026-08-27 10:00:22

At Rs 271.5, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 3.24% on 27 Aug 2026, with unfilled sell orders and a frozen price.

Read full news article

Bafna Pharmaceuticals Ltd is Rated Sell

2026-08-26 10:11:12

Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

2026-08-26 10:00:32

At Rs 280.6, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 26 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

View All News